Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review

Yaping Liu,Jiapeng Li,Hao-Jie Zhu
DOI: https://doi.org/10.1080/17425255.2024.2348491
2024-05-07
Expert Opinion on Drug Metabolism & Toxicology
Abstract:Introduction Carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) are among the most abundant hydrolases in humans, catalyzing the metabolism of numerous clinically important medications, such as methylphenidate and clopidogrel. The large interindividual variability in the expression and activity of CES1 and CES2 affects the pharmacokinetics (PK) and pharmacodynamics (PD) of substrate drugs.
pharmacology & pharmacy,biochemistry & molecular biology,toxicology
What problem does this paper attempt to address?